10:58:46 EDT Sun 26 May 2019
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for U:HALO from 2018-05-25 to 2019-05-24 - 46 items News ReleasesIn The NewsOther
DateSymPriceTypeHeadline
2019-05-22 01:05HALONews ReleaseHalozyme Announces argenx Has Selected Second Target Under ENHANZE ® Technology Collaboration And License Agreement
2019-05-13 08:01HALONews ReleaseHalozyme To Participate In Bank of America Merrill Lynch Health Care Conference 2019
2019-05-07 16:01HALONews ReleaseHalozyme Reports First Quarter 2019 Results
2019-05-06 08:00HALONews ReleaseHalozyme Names Dr. Alison A. Armour As Senior Vice President Of Research And Development
2019-04-30 03:00HALONews ReleaseHalo Labs Begins Trading on the OTCQX Market
2019-04-23 16:01HALONews ReleaseHalozyme To Host First Quarter 2019 Financial Results Webcast And Conference Call
2019-03-04 08:01HALONews ReleaseHalozyme To Participate In Upcoming Investor Conferences
2019-02-28 11:47HALONews ReleaseHalozyme Announces FDA Approval Of Herceptin Hylecta ™
2019-02-21 16:01HALONews ReleaseHalozyme Reports Fourth Quarter And Full-Year 2018 Results
2019-02-15 08:20HALONews ReleaseConsolidated Research: 2019 Summary Expectations for Tenaris S.A, Rapid7, Halozyme Therapeutics, Cara Therapeutics, EnPro Industries, and K12 — Fundamental Analysis, Key Performance Indications
2019-02-07 16:01HALONews ReleaseHalozyme To Host Fourth Quarter And Full-Year 2018 Financial Results Webcast And Conference Call
2019-02-04 01:00HALONews Releaseargenx and Halozyme Enter Global Collaboration and License Agreement for ENHANZE ® Technology
2019-01-09 13:30HALONews ReleaseHalozyme Provides 2019 Pipeline Update And Financial Guidance At 37th Annual JP Morgan Healthcare Conference
2018-12-27 07:25HALONews ReleaseFactors of Influence in 2019, Key Indicators and Opportunity within Halozyme Therapeutics, Capricor Therapeutics, Appian, Yext, Agile Therapeutics, and Corbus Pharmaceuticals — New Research Emphasizes Economic Growth
2018-12-26 08:00HALONews ReleaseHalozyme Therapeutics To Present At The 37th Annual J.P. Morgan Healthcare Conference
2018-12-03 17:05HALONews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. – HALO
2018-12-03 16:59HALONews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. – HALO
2018-11-29 16:16HALONews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO
2018-11-29 16:16HALONews ReleaseSHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Halozyme Therapeutics, Inc. - HALO
2018-11-29 14:33HALONews ReleaseSHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Halozyme Therapeutics, Inc. (HALO)
2018-11-26 16:05HALONews ReleaseHalozyme Announces Change In Primary Endpoint For HALO-301 To Overall Survival
2018-11-08 07:40HALONews ReleaseReport: Exploring Fundamental Drivers Behind Entergy, BLACKLINE INC, HollyFrontier, Hill-Rom, Apache, and Halozyme Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
2018-11-06 16:05HALONews ReleaseHalozyme Reports Third Quarter 2018 Financial Results
2018-11-06 08:00HALONews ReleaseHalozyme Names Albert Kildani As Vice President Investor Relations And Corporate Communications
2018-10-30 08:00HALONews ReleaseHalozyme Licenses New ENHANZE ® Targets For $25 Million Upfront Payment, Future Milestones And Royalties
2018-10-25 08:00HALONews ReleaseHalozyme Announces First Clinical Dosing In Bristol-Myers Squibb's Phase 1 Trial Of BMS-986179 With Enhanze ® Technology
2018-10-22 08:00HALONews ReleaseHalozyme Provides Summary Results Of Data For PEGPH20 Combination Treatments Presented At ESMO 2018 Congress
2018-10-17 09:00HALONews ReleaseMarket Trends Toward New Normal in Halozyme Therapeutics, Fitbit, Iconix Brand Group, Leap Therapeutics, LightPath Technologies, and Capricor Therapeutics — Emerging Consolidated Expectations, Analyst Ratings
2018-10-10 16:05HALONews ReleaseHalozyme To Host Third Quarter 2018 Financial Results Conference Call
2018-10-04 09:00HALONews ReleaseHalozyme Publication In The Journal Clinical Cancer Research Highlights New Nonclinical Data Supporting Multiple Effects Of PEGPH20 On The Tumor Microenvironment
2018-09-20 16:15HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Investor Conference
2018-09-17 08:00HALONews ReleaseHalozyme Announces Approval Of Subcutaneous Formulation Of Trastuzumab (Herceptin ®) In Canada
2018-09-10 08:00HALONews ReleaseHalozyme Appoints Bernadette Connaughton To Board Of Directors
2018-09-05 08:00HALONews ReleaseHalozyme Names Benjamin Hickey As Chief Commercial Officer
2018-08-23 10:30HALONews ReleaseRecent Analysis Shows KB Home, Sleep Number, Exelixis, Sprint, PayPal, and Halozyme Therapeutics Market Influences — Renewed Outlook, Key Drivers of Growth
2018-08-22 08:30HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Investor Conferences
2018-08-07 16:21HALONews ReleaseHalozyme Reports Second Quarter 2018 Results
2018-08-07 15:46HALONews ReleaseHalozyme Therapeutics, Inc. to Host Earnings Call
2018-07-26 16:15HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Healthcare Conference
2018-07-26 08:00HALONews ReleasePhase 3 Study Of Subcutaneous Pertuzumab And Trastuzumab Initiated Using Halozyme's ENHANZE ® Technology
2018-07-11 08:30HALONews ReleaseFDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
2018-07-06 08:00HALONews ReleaseHalozyme To Host Second Quarter 2018 Financial Results Conference Call
2018-06-13 08:00HALONews ReleaseReport: Exploring Fundamental Drivers Behind Virtu Financial, Littelfuse, Gogo, Brookfield Asset Management, Protalix BioTherapeutics, and Halozyme Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments
2018-06-11 08:30HALONews ReleaseHalozyme President And Chief Executive Officer, Dr. Helen Torley Named EY Entrepreneur Of The Year 2018 San Diego
2018-06-01 08:30HALONews ReleaseHalozyme Identifies Plasma Biomarkers As Potential Predictors Of Survival In Pancreatic Cancer
2018-05-29 16:15HALONews ReleaseHalozyme Therapeutics To Participate In Upcoming Healthcare Conferences